Vanderbilt-Ingram Cancer Center: Neoplasms trials

The registry lists 17 Neoplasms studies with Vanderbilt-Ingram Cancer Center as lead sponsor. 4 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 4Phase 2 3Phase 3 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell CarcinomaRecruitingNCT07217028Phase 1
• High-Resolution PET-CT Imaging for Surgical Margin VisualizationRecruitingNCT06915454Not applicable
• Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
• Inherited CAncer REgistryRecruitingNCT03231891
• High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell TransplantCompletedNCT02860039Phase 2Results posted
• Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderCompletedNCT00755040Phase 3Results posted
• Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainCompletedNCT00666211Phase 3Results posted
• Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or MelanomaTerminatedNCT00512798Phase 1/2Results posted
• PCRC-Supported Legacy Intervention in Pediatric Palliative CareCompletedNCT04059393Not applicable
• Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy InfusionTerminatedNCT04034914Not applicable
• Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceActive, not recruitingNCT03694249Phase 2
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
• Quantitative MRI in Assessing Disease in Patients With Brain TumorsTerminatedNCT02269111Not applicable
• Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell TransplantTerminatedNCT02240381Not applicable
• Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantCompletedNCT00900406
• T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
• Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain MetastasesTerminatedNCT00469937Phase 1